From: Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study
Total | 1826 (100%) |
---|---|
Aerobic Gram-negative bacteria | 1152 (63%) |
Escherichia coli | 653 (35.7%) |
(Escherichia coli resistant to third generation cephalosporins) | 110 (6%) |
Klebsiella pneuumoniae | 181 (9.9%) |
(Klebsiella pneumoniae resistant to third generation cephalosporins) | 39 (2.1%) |
Klebsiella oxytoca | 11 (0.6%) |
(Klebsiella oxytoca resistant to third generation cephalosporins) | 2 (0.1) |
Enterobacter | 75 (4.1%) |
Proteus | 52 (2.8%) |
Pseudomonas | 94 (5.1%) |
Others | 102 (5.6%) |
Aerobic Gram-positive bacteria | 414 (22.7%) |
Enterococcus faecalis | 169 (9.2%) |
Enterococcus faecium | 68 (3.7%) |
Staphylococcus Aureus | 46 (2.5%) |
Streptococcus spp. | 85 (4.6%) |
Others | 47 (2.6%) |
Anaerobes | 141 (7.7%) |
Bacteroides | 108 (5.9%) |
(Bacteroides resistant to Metronidazole) | 3 (0.2%) |
Clostridium | 11 (0.6%) |
Others | 22 (1.2%) |
Candida spp. | 117 (6.4%) |
Candida albicans | 90 (4.9%) |
(Candida albicans resistant to Fluconazole) | 2 (0.1%) |
Non-albicans Candida | 27 (1.4%) |
(non-albicans Candida resistant to Fluconazole) | 3 (0.1%) |
Other yeats | 2 (0.1%) |